XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Warrants
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018   43,578      
Beginning balance at Dec. 31, 2018 $ 102,231 $ 471,180 $ 104 $ (39) $ (369,014)
Increase (Decrease) in Shareholders' Equity          
Net income (loss) (2,844)       (2,844)
Compensation expense related to stock options and restricted stock units granted, net of forfeitures 2,628 $ 2,628      
Stock option exercises (in shares)   228      
Stock option exercises 780 $ 780      
Shares issued under the Employee Stock Purchase Plan (in shares)   19      
Shares issued under the Employee Stock Purchase Plan 218 $ 218      
Unrealized gain (loss) on investments 42     42  
Ending balance (in shares) at Mar. 31, 2019   43,825      
Ending balance at Mar. 31, 2019 103,055 $ 474,806 104 3 (371,858)
Beginning balance (in shares) at Dec. 31, 2018   43,578      
Beginning balance at Dec. 31, 2018 102,231 $ 471,180 104 (39) (369,014)
Increase (Decrease) in Shareholders' Equity          
Net income (loss) (19,166)        
Unrealized gain (loss) on investments 29        
Ending balance (in shares) at Sep. 30, 2019   44,520      
Ending balance at Sep. 30, 2019 96,990 $ 485,141 0 29 (388,180)
Beginning balance (in shares) at Mar. 31, 2019   43,825      
Beginning balance at Mar. 31, 2019 103,055 $ 474,806 104 3 (371,858)
Increase (Decrease) in Shareholders' Equity          
Net income (loss) (19,792)       (19,792)
Compensation expense related to stock options and restricted stock units granted, net of forfeitures 4,183 $ 4,183      
Stock option exercises (in shares)   227      
Stock option exercises 850 $ 850      
Shares issued under the Employee Stock Purchase Plan (in shares)   14      
Shares issued under the Employee Stock Purchase Plan 211 $ 211      
Unrealized gain (loss) on investments 35     35  
Ending balance (in shares) at Jun. 30, 2019   44,066      
Ending balance at Jun. 30, 2019 88,542 $ 480,050 104 38 (391,650)
Increase (Decrease) in Shareholders' Equity          
Net income (loss) 3,470       3,470
Compensation expense related to stock options and restricted stock units granted, net of forfeitures 3,285 $ 3,285      
Stock option exercises (in shares)   416      
Stock option exercises 1,427 $ 1,427      
Shares issued under the Employee Stock Purchase Plan (in shares)   18      
Shares issued under the Employee Stock Purchase Plan 275 $ 275      
Unrealized gain (loss) on investments (9)     (9)  
Exercise of warrants resulting in the issuance of common stock (in shares)   20      
Exercise of warrants resulting in issuance of common stock 0 $ 104 (104)    
Ending balance (in shares) at Sep. 30, 2019   44,520      
Ending balance at Sep. 30, 2019 96,990 $ 485,141 0 29 (388,180)
Beginning balance (in shares) at Dec. 31, 2019   44,864      
Beginning balance at Dec. 31, 2019 111,091 $ 489,749 0 21 (378,679)
Increase (Decrease) in Shareholders' Equity          
Net income (loss) (4,705)       (4,705)
Compensation expense related to stock options and restricted stock units granted, net of forfeitures 3,768 $ 3,768      
Stock option exercises (in shares)   57      
Stock option exercises 196 $ 196      
Shares issued under the Employee Stock Purchase Plan (in shares)   20      
Shares issued under the Employee Stock Purchase Plan 224 $ 224      
Issuance of stock upon restricted stock unit vesting (in shares)   36      
Issuance of stock upon restricted stock unit vesting 0        
Restricted stock withheld for employee tax remittance (in shares)   (14)      
Restricted stock withheld for employee tax remittance (163) $ (163)      
Unrealized gain (loss) on investments 41     41  
Ending balance (in shares) at Mar. 31, 2020   44,963      
Ending balance at Mar. 31, 2020 110,452 $ 493,774 0 62 (383,384)
Beginning balance (in shares) at Dec. 31, 2019   44,864      
Beginning balance at Dec. 31, 2019 111,091 $ 489,749 0 21 (378,679)
Increase (Decrease) in Shareholders' Equity          
Net income (loss) (9,356)        
Unrealized gain (loss) on investments 57        
Ending balance (in shares) at Sep. 30, 2020   45,315      
Ending balance at Sep. 30, 2020 114,630 $ 502,587 0 78 (388,035)
Beginning balance (in shares) at Mar. 31, 2020   44,963      
Beginning balance at Mar. 31, 2020 110,452 $ 493,774 0 62 (383,384)
Increase (Decrease) in Shareholders' Equity          
Net income (loss) (8,269)       (8,269)
Compensation expense related to stock options and restricted stock units granted, net of forfeitures 4,376 $ 4,376      
Stock option exercises (in shares)   188      
Stock option exercises 696 $ 696      
Shares issued under the Employee Stock Purchase Plan (in shares)   32      
Shares issued under the Employee Stock Purchase Plan 257 $ 257      
Issuance of stock upon restricted stock unit vesting (in shares)   11      
Issuance of stock upon restricted stock unit vesting 0        
Unrealized gain (loss) on investments 84     84  
Ending balance (in shares) at Jun. 30, 2020   45,194      
Ending balance at Jun. 30, 2020 107,596 $ 499,103 0 146 (391,653)
Increase (Decrease) in Shareholders' Equity          
Net income (loss) 3,618       3,618
Compensation expense related to stock options and restricted stock units granted, net of forfeitures 2,675 $ 2,675      
Stock option exercises (in shares)   77      
Stock option exercises 500 $ 500      
Shares issued under the Employee Stock Purchase Plan (in shares)   44      
Shares issued under the Employee Stock Purchase Plan 309 $ 309      
Unrealized gain (loss) on investments (68)     (68)  
Ending balance (in shares) at Sep. 30, 2020   45,315      
Ending balance at Sep. 30, 2020 $ 114,630 $ 502,587 $ 0 $ 78 $ (388,035)